Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Providing essential cancer care to rural communities
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
4.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
5.
How Do Younger People Fare With Stool Tests for CRC Screening?
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review
3.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation